Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey
Selami Bayram, Bahadır Köylü, Maral Martin Mıldanoğlu, Mustafa Serkan Alemdar, Tahir Yerlikaya, Fatih Selçukbiricik, Ahmet Bilici, Ali Murat Tatli, Mustafa Ozdogan · 2026
Read Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey by Selami Bayram, Bahadır Köylü, Maral Martin Mıldanoğlu, Mustafa Serkan Alemdar, Tahir Yerlikaya, Fatih Selçukbiricik, Ahmet Bilici, Ali Murat Tatli, Mustafa Ozdogan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13114962.txt.
Description
Selami Bayram and co-authors profile gene changes in pancreatic cancer patients in Turkey and link them to survival. Their 2026 study deals with a highly lethal cancer of the pancreas. Gene sequencing can reveal changes that drugs may target. Yet real world data linking gene groups to survival are scarce. Records covered patients diagnosed from 2017 to 2025 who had tumor sequencing in routine care.
In all, ninety eight patients were profiled, and ninety two had survival data. A gene called KRAS was changed in 83.7 percent of cases. Survival was timed from spread of the disease, or from the start of first treatment for treated patients. Standard survival curves and adjusted models were used. The study maps the gene landscape of this cohort in daily practice.
Catalog record
| CREATOR | Selami Bayram, Bahadır Köylü, Maral Martin Mıldanoğlu, Mustafa Serkan Alemdar, Tahir Yerlikaya, Fatih Selçukbiricik, Ahmet Bilici, Ali Murat Tatli, Mustafa Ozdogan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |